Life Sciences

EXMceuticals Inc. (“EXM”) is a cannabis wholesale company with a head office in Vancouver, British Columbia and operations in the Democratic Republic of Congo, Malawi, Portugal and Uganda. EXM also has an experienced international team that has a deep working-knowledge of agriculture and Africa.  EXM’s activities are focused on the sustainable cultivation of cannabis and hemp, and the production of pharmaceutical grade, psychotropic and non-psychotropic cannabis and hemp ingredients for the pharmaceutical, therapeutical and nutraceutical industries.  The company aims to offer the most secure supply chain of cannabinoid ingredients that exists in industry and export the extracted ingredients to international markets. In addition, the company wishes to enhance living conditions locally through its buy local, hire local policy and through local foundations. EXM is in the process of obtaining additional licenses and establishing operations across multiple sites in Africa, including Ethiopia, Zambia and Burundi.  In addition, EXM is in the process of obtaining a license in Portugal for the establishment of a research laboratory, a nursery, and a center for processing and distribution.  EXM uses the Supercritical CO2 method for extraction – a chemical-free process that offers high molecule separation strength. By using this method, EXM will provide to customers a pure, natural product of superior quality. EXM can rely on important R&D and distribution partners to complete their expertise.

Flower One Holdings Inc. (“FONE”) is a company with strategic investments in the cannabis sector through its wholly-owned subsidiaries. FONE’s wholly-owned subsidiaries are located in Nevada where it is currently converting the largest commercial scale greenhouse in the State. The 455,000 square foot facility will be used for cannabis cultivation as well as the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use